Table 5. Comparison of HS Serotypes with Proportional Estimates by Region: Proportions that met or exceeded the 2% threshold are bolded and those that did not are indicated in italics.

	Global %	Africa %	Asia %	Europe %	N. America %	Oceania %
	(n = 21,394)	(n = 566)	(n = 1,186)	(n = 18,184)	(n = 763)	(n = 695)
HS4c	15.3	7.0	8.9	17.3	23.5	17.4
HS2	13.5	6.2	11.5	15.3	10.7	18.2
HS1/44	8.2	6.8	4.2	9.1	9.3	10.5
HS11	3.1	1.6	0.2	4.0	3.6	1.7
HS5/31	2.9	6.2	1.8	2.6	6.8	1.5
HS8/17	2.8	4.1	2.9	2.2	5.3	8.8
HS6/7	2.4	1.2	0.7	3.6	2.3	0.6
HS3	2.2	6.3	2.6	1.9	4.9	0.7
HS37	1.8	0.9	2.4	1.8	2.1	1.8
HS23/36	1.7	4.2	3.0	1.4	1.8	4.2
HS21	1.6	0.5	0.6	1.8	2.5	1.1
HS19	1.5	2.0	3.1	1.5	0.9	0.5
HS12	1.3	1.0	0.0	2.1	0.5	0.7
HS58	1.3	0.8	0.0	2.0	1.0	0.1
HS15	1.1	1.4	3.4	1.2	0.9	0.4
HS18	0.9	0.4	0.1	1.1	2.1	0.2
HS53	0.7	3.3	1.2	0.7	0.6	0.1